Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Albiglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Contact us to learn more
ArticlePubMed 2
Diabetes Care 27 , 155161 (2004)
We do have: 10+ year safety data for earlier GLP-1 agonists (liraglutide, exenatide) Growing evidence of cardiovascular benefits from weight loss medications Understanding that obesity itself has well-documented health risks The risk-benefit calculation often favors treatment, but this is an individual decision that should be made with your healthcare provider based on your specific medical situation
US$ 19.98
US$ 21.46
US$ 23.90
US$ 28.25
US$ 27.53
US$ 20.46
US$ 22.51
